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The PathoLogic component of the Pathway Tools software performs prediction of metabolic 
pathways in sequenced and annotated genomes. This article provides a detailed presentation 
of the PathoLogic algorithm. The algorithm consists of two phases. The reactome inference 
phase infers the reactions catalyzed by the organism from the set of enzymes present in the 
annotated genome. The pathway inference phase infers the metabolic pathways present in 
the organism from the reactions catalyzed by the organism. Both phases draw on the Me-
taCyc database of metabolic reactions and pathways. MetaCyc contains two data fields to 
support pathway inference: the expected taxonomic range of each pathway, and a list of key 
reactions for pathways. These fields have significantly increased the predictive accuracy of 
PathoLogic. 
Overview 
We describe the metabolic pathway prediction 
algorithm used by the Pathway Tools software 
[1,2]. Pathway Tools is in use by a large number of 
groups to reconstruct the metabolic pathway 
complement of organisms from their annotated 
genomes, and to create curated metabolic path-
way databases. For example, the SRI BioCyc data-
base collection [3,4] contains Pathway/Genome 
Databases (PGDBs) for 1,004 genomes, and Mi-
croCyc [5] contains 535 genomes. Curated Path-
way Tools-based PGDBs are available for Mus 
musculus [6], Saccharomyces cerevisiae [7], Arabi-
dopsis thaliana  [8],  Drosophila melanogaster  [9], 
Escherichia coli [10], and Homo sapiens [11]. See 
[12] for a comprehensive listing of Web-accessible 
PGDBs. 
The Pathway Tools pathway prediction algorithm 
predicts pathways in a sequenced genome by re-
cognizing in that genome previously known path-
ways from the MetaCyc database [4]. Pathways 
are recognized based on the enzymes present in 
the genome. Pathway Tools does not perform se-
quence analysis and it does not predict the func-
tions of the proteins in a genome. It assumes that 
the genome has already been annotated using one 
of the many available genome annotation pipe-
lines, such as [13,14]. 
Pathway Tools contains several computational 
inference components [1], which are collectively 
called PathoLogic. Henceforth, this article will use 
the term PathoLogic to refer to the Pathway Tools 
pathway prediction algorithm. 
Background: The MetaCyc Pathway 
Database 
The MetaCyc metabolic database is the reference 
pathway database used by PathoLogic for path-
way prediction [Figure 1]. Version 14.6 (released 
in November 2010) of MetaCyc contains 1,583 
base metabolic pathways and 263 superpathways. 
The pathway  information in MetaCyc has been 
specially honed to support pathway prediction in 
the following respects. First, curators sometimes 
divide pathways into smaller segments that cor-
respond to atomic units conserved by evolution. 
This process is informed by curators observations 
of which pathway segments occur in different or-
ganisms, and can yield more accurate pathway 
predictions. For example, imagine that organism A 
contains a linear pathway P1 consisting of six con-
secutive reactions, R1–R6. Imagine, however, that 
organism B contains a smaller portion of P1 con-
sisting of reactions R4–R6, which we will call P2. If 
P1 were present in MetaCyc and we were per-Karp PD, Latendresse M, and Caspi R 
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forming a pathway prediction in organism B, and 
B contained enzymes for reactions R4–R6, we 
would predict P1 as present in B. However, this 
inference would be incorrect because B in fact 
contains the shorter pathway P2. When MetaCyc 
curators encounter this situation, they define 
pathway P2 in MetaCyc, and a new pathway P3 
consisting of reactions R1–R3. Pathway P1 will be 
redefined as a superpathway containing P2 and 
P3. In this way PathoLogic can properly recognize 
whichever of P1, P2, or P3 is present in a given 
genome. 
A second way in which MetaCyc is optimized for 
pathway prediction is that it contains information 
on the expected taxonomic groups in which most 
MetaCyc pathways occur. Curators have recorded 
this taxonomic range information (in slot Tax-
onomic–Range) at whatever granularity they 
deem appropriate to capture their expectation of 
the taxonomic groups in which the pathway will 
be found. Taxonomic range assignments vary from 
very broad (e.g., “Bacteria”) to very specific (e.g., 
“Mycoplasma”), and are based on both the tax-
onomic groups in which the pathway is known to 
occur, and the function of the pathway. The next 
section describes how PathoLogic uses taxonomic 
range information. 
MetaCyc curators sometimes specify key reactions 
within a pathway. Key reactions are used by Pa-
thoLogic to differentiate between related pathway 
variants. Key reactions are reactions whose pres-
ence is considered as a critical signature for the 
presence of the pathway. 
MetaCyc contains a large collection of enzyme 
names obtained from the Enzyme Nomenclature 
List prepared by the International Union of Bio-
chemistry and Molecular Biology [15] and from 
the MetaCyc curators. Approximately 24,000 en-
zyme names are present in MetaCyc version 14.6. 
 
Figure 1. Example pathway illustrating how 
MetaCyc curators sometimes split pathways 
into smaller evolutionarily conserved units. The Pathway Tools Pathway Prediction Algorithm 
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Procedures Used 
Pathway prediction is divided into two phases: 
prediction of the reactome (reaction complement) 
of the organism, and prediction of pathway com-
plement of the organism from its predicted reac-
tome. 
Input to PathoLogic 
The input to PathoLogic is an annotated genome. 
The genome is provided as a set of files. For each 
replicon or contig in the genome, the user pro-
vides: 
• An annotation file, in either Genbank 
format [16] or in PathoLogic format 
[17] 
•  A sequence file, formatted in FASTA 
format (Optional) 
We have found that considerable variability exists 
in how different groups interpret the Genbank file 
format, and that it is not unusual to find Genbank 
files that are incompatible with the interpretation 
used by PathoLogic. Therefore, if Genbank format 
files are provided, care should be exercised in de-
termining that proper tag names are used within 
the file (e.g., gene product names should be pro-
vided within the /product tag), and that informa-
tion is formatted properly within each tag (e.g., 
product names such as “tryptophan synthetase” 
should not be suffixed or prefixed with additional 
information such as gene names, protein length, 
etc.). Exact details of expected file formats are 
provided in the Pathway Tools User’s Guide [17]. 
Reactome Inference 
The first step in pathway prediction is to infer the 
set of biochemical reactions that can be catalyzed 
by the enzymes encoded by the genome, that is, to 
infer the reactome of the organism. Because reac-
tions are the direct building blocks of pathways, 
once we know the reactome of the organism, we 
can more easily assess the evidence for what 
pathways are present. 
The output of the reactome inference phase is the 
set of inferred reactions. All inferred reactions and 
their substrates are copied from MetaCyc to the 
organism-specific PGDB. 
The PathoLogic reactome inference module ex-
amines each gene product in the genome, and at-
tempts to infer what if any reactions are catalyzed 
by that gene product. Often no reactions are in-
ferred since many genes have no assigned func-
tion, and many genes that have assigned functions 
are not metabolic enzymes (e.g., transcription fac-
tors and histones do not have enzymatic activi-
ties). 
The reactions catalyzed by a gene product are in-
ferred from three information fields present in the 
Genbank or PathoLogic file for a gene product: the 
EC number, gene product name (enzyme name), 
and Gene Ontology (GO) terms. Ideally, the user 
would provide the gene product name plus either 
the EC number or GO terms (note that EC number 
and GO terms are redundant to a significant de-
gree since a large number of Gene Ontology mole-
cular function terms correspond directly to EC 
numbers). We prefer to have EC number or GO 
terms provided because these terms are from a 
controlled vocabulary and are therefore much eas-
ier to recognize than are uncontrolled enzyme 
names. However, many metabolic enzymes have 
not yet been assigned EC numbers or GO terms; 
therefore, controlled vocabulary terms cannot be 
assigned to many metabolic enzymes. For multi-
functional enzymes, a gene product name and ei-
ther EC number or GO terms should be provided 
for each enzyme function. 
We emphasize that it is the preceding information 
only that is used to infer the reaction(s) catalyzed 
by each gene product. Sequence information is not 
used by PathoLogic in reactome inference. Note 
also that many reactions predicted by PathoLogic 
do not end up being attached to metabolic path-
ways after PathoLogic pathway inference, which 
can occur because a reaction is not a component of 
any pathway in MetaCyc, and because no pathway 
of which the reaction is a component was inferred 
as present in the PGDB. 
The reactome inference module also compares the 
reactions inferred from enzyme name, EC num-
bers, and GO terms to ensure that they are consis-
tent. If, for example, the enzyme name and EC 
number identify reaction sets with a null intersec-
tion, then a warning is produced, and PathoLogic 
infers the reaction for the EC number. 
The reactome inference algorithm infers the reac-
tions catalyzed by protein P as follows. Karp PD, Latendresse M, and Caspi R 
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1.   For each EC number ECi attached to P, look 
up all reactions R annotated with ECi in Me-
taCyc. Infer that P catalyzes every reaction in 
R for each ECi. 
2.   If GO terms are attached to P, their asso-
ciated EC numbers (if any) are also used in 
the previous step. 
3.   For each enzyme name (gene product name) 
ENi attached to P, perform a lookup of ENi in 
MetaCyc. If a single matching reaction is as-
sociated with ENi, infer that P catalyzes the 
reaction associated with ENi in MetaCyc. The 
lookup of ENi in MetaCyc involves the fol-
lowing processing: 
• Convert ENi to lower case and 
remove punctuation characters 
such as space and hyphen to 
eliminate variation in styling of 
enzyme names. 
• Look up ENi in MetaCyc. If found, 
declare a match and stop any fur-
ther searching. If not found, try 
the following step. 
• Remove various prefixes and suf-
fixes, one at a time, from ENi that 
can interfere with matching such 
as “putative,” “hypothetical,” “pre-
dicted,” “precursor,” “secreted,” 
and many other qualifiers, some 
based on regular expressions. For 
each removal, search for the re-
duced name in MetaCyc. Once a 
match is found, declare a match 
and stop further searching. 
• If the same enzyme name matches 
multiple reactions, flag the name 
as ambiguous and do not infer 
reactions for it. 
Pathway Inference 
Pathway inference is based on the set of catalyzed 
reactions that were imported from MetaCyc dur-
ing the reactome inference step. All pathways in-
ferred during the phase described have also come 
from a fixed reference database, namely MetaCyc. 
In the following when we say a pathway is in-
ferred, it means that PathoLogic has predicted that 
the pathway is present in this organism. All in-
ferred pathways are copied from MetaCyc to the 
PGDB being generated for this organism. When we 
say a reaction is present in the generated PGDB, 
we mean the reaction has been inferred as present 
in the organism by the reactome inference step, or 
that the reaction is marked as spontaneous in Me-
taCyc. 
Inference of a pathway is based on the approach 
that if no rule can be found to reject (i.e., not infer) 
a pathway, then the pathway should be inferred as 
present in that PGDB. PathoLogic applies the fol-
lowing rules to infer pathways. The rules are ap-
plied to base pathways (not to super pathways) 
individually and in no particular order. 
 
Rules for inferring base pathways: 
1.   If a pathway is mostly absent in the generated 
PGDB, it is not inferred. A pathway is mostly 
absent if it has more than one missing reaction 
in the generated PGDB, and if it has no more 
than one reaction present. 
2.   A reaction is unique (to a pathway) if the reac-
tion is used in only one pathway in the gener-
ated PGDB. If a pathway P has a unique reac-
tion, considering the pathways that were not 
inferred, P is inferred. In the particular case 
that two or more pathways share a unique 
reaction among them (meaning the reaction is 
found only in that set of pathways), and the 
only reason to keep these pathways is based 
on the uniqueness of that reaction, then one of 
the pathways is randomly selected to be kept. 
3.   A biosynthetic pathway that is a proper subset 
of some other pathway and is missing its final 
two reactions is not inferred. Similarly, a de-
gradative pathway that is a proper subset of 
some other pathway and is missing its initial 
step is not inferred. The intuition behind the 
preceding rules is that multiple biosynthetic 
pathways sometimes share common initial 
steps, and it is the final steps that are most in-
dicative of the presence of the pathway (and 
conversely for catabolic pathways). An energy 
metabolism pathway with no unique reactions 
having fewer than half of the reactions present 
in the generated PGDB is not inferred. 
4.  If the reactions in a pathway P1 are a superset 
of the reactions of an already inferred pathway 
P2, and P1 has more missing reactions than 
P2, P1 is not inferred. The Pathway Tools Pathway Prediction Algorithm 
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5.  MetaCyc pathways contain taxonomic range 
assignments that indicate the range of organ-
isms in which a pathway is likely to be found. 
Because MetaCyc taxonomic range assign-
ments are approximate and are based on in-
complete knowledge, PathoLogic does allow 
pathways to be inferred in organisms outside 
their taxonomic range, but it requires very 
stringent evidence to do so. A pathway outside 
its taxonomic range will be predicted as 
present if and only if all reactions in the path-
way are present in the generated PGDB. The 
use of the taxonomic range information can be 
deactivated by the user. 
6.  Many pathways of MetaCyc have some reac-
tions designated as key reactions. Any path-
way that is missing at least one key reaction in 
the generated PGDB is not inferred. If all key 
reactions of a pathway are present in the gen-
erated PGDB, the pathway is inferred. 
7.  Electron transfer pathways are inferred if and 
only if they are complete, that is if and only if 
all their reactions are present in the generated 
PGDB. No other electron transport pathways 
are inferred. 
Rules for inferring superpathways: 
1.   MetaCyc contains superpathways composed of 
individual (base) pathways, or a combination 
of base pathways and superpathways. A Me-
taCyc superpathway is inferred in the generat-
ed PGDB if and only if all its component super-
pathways and base pathways are present in 
the generated PGDB. Since superpathways can 
be part of other super-pathways, the decision 
to include or exclude a superpathway is per-
formed recursively starting from the super-
pathways that do not include any child super-
pathways. 
Discussion 
An evaluation of the PathoLogic algorithm per-
formed one year ago [2] using a gold-standard 
pathway database found its accuracy ((true posi-
tives plus true negatives) divided by all examples) 
to be 91%, its specificity (true negatives divided 
by all negatives) to be 94%, its precision (true po-
sitives divided by (true positives plus false posi-
tives)) to be 77.9%, and its sensitivity (true posi-
tives divided by all positives) to be 79.3%. Since 
then we have made a number of small improve-
ments to the algorithm that have likely improved 
its accuracy [1]. 
As MetaCyc has grown in size in the last several 
years it has been a challenge to maintain the accu-
racy of PathoLogic. The introduction of key reac-
tions and taxonomic range information in MetaCyc 
increased the accuracy of PathoLogic substantial-
ly. We have recently improved the speed of Patho-
Logic by approximately a factor of 5 to decrease 
the time it requires to process large metagenomics 
datasets. To our knowledge, the pathway predic-
tion algorithms used by KEGG and Reactome have 
not been published. Therefore, we cannot com-
pare our algorithm to theirs. 
PathoLogic can generate a “pathway evidence 
report” Web page that lists all pathways it has 
predicted in an organism and the evidence sup-
porting each predicted pathway (example page 
[18] ). This report provides a convenient way for 
a scientist to review the evidence for each path-
way. The pathways are grouped by the MetaCyc 
pathway ontology. For each predicted pathway 
the report shows a low-resolution pathway dia-
gram that indicates which reactions in the path-
way are present in the organism, the total count 
of reactions present, the number of reactions that 
are used in other pathways, and a list of those 
other pathways. 
Availability 
MetaCyc is freely and openly available to all users. 
Pathway Tools runs on Linux, Windows, and Ma-
cintosh; it is freely available to academic users, 
and is available to commercial users for a fee. Me-
taCyc and Pathway Tools may be obtained from 
[19]. 
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